Results 51 to 60 of about 44,370 (261)

Twenty years of inhaler therapy: A nationwide drug utilization study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to map nationwide trends and prescribing patterns in inhaler use from 2004 to 2023. In light of evolving clinical guidelines and attention to the environmental impact of inhalers within recent years, we also examined variation in prescribing behaviour and patient‐level treatment choices. Methods Using nationwide health registries,
Katrine Bitsch Johansen, Lars Christian Lund, Zandra Nymand Ennis, Andrew Scourfield, Anders Løkke, Sidsel Arnspang Pedersen   +5 more
wiley   +1 more source

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

Journal of Asthma and Allergy, 2023
Richard N van Zyl-Smit,1 Kenneth R Chapman,2 Huib AM Kerstjens,3 Christian Gessner,4 Hironori Sagara,5 Ana-Maria Tanase,6 Motoi Hosoe,6 Abhijit Pethe,7 David Lawrence,6 Hanns-Christian Tillmann,8 Peter D’Andrea7 1Division of Pulmonology and UCT Lung ...
van Zyl-Smit RN, Chapman KR, Kerstjens HAM, Gessner C, Sagara H, Tanase AM, Hosoe M, Pethe A, Lawrence D, Tillmann HC, D'Andrea P   +10 more
doaj  

Chest Pain Relieved with a Bronchodilator or Other Asthma Drugs

Allergology International, 2009
Background: Although many patients who experience chest pain or pressure consult their physicians, unfortunately a large number of them do not, and consequently they remain undiagnosed and untreated.
Hirokazu Taniguchi, Kenta Kanbara, Kiyoshi Hoshino, Saburo Izumi   +3 more
doaj   +1 more source

COPD: maximization of bronchodilation [PDF]

Multidisciplinary Respiratory Medicine, 2014
The most recent guidelines define COPD in a multidimensional way, nevertheless the diagnosis is still linked to the limitation of airflow, usually measured by the reduction in the FEV1/FVC ratio below 70%. However, the severity of obstruction is not directly correlated to symptoms or to invalidity determined by COPD.
Stefano Nardini, CAMICIOTTOLI, GIANNA, Salvatore Locicero, Rosario Maselli, Franco Pasqua, Giovanni Passalacqua, Riccardo Pela, Alberto Pesci, Alfredo Sebastiani, Alessandro Vatrella   +9 more
openaire   +6 more sources

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Bronchodilator responsiveness and reported respiratory symptoms in an adult population. [PDF]

, 2013
The relationship between patient-reported symptoms and objective measures of lung function is poorly understood.To determine the association between responsiveness to bronchodilator and respiratory symptoms in random population samples.4669 people aged ...
A. Sonia Buist (390258), Robert Cowie, Kenneth R. Chapman (390254), Shawn Aaron (390256), CanCOLD Collaborative Research Group, Don D. Sin (116489), Wan C Tan, Kenneth R Chapman, Denis E. O’Donnell (390259), Robert Cowie (390255), Paul Hernandez (390253), Darcy D Marciniuk, Francois Maltais, A Sonia Buist, J Mark FitzGerald, Darcy D. Marciniuk (390257), Jean Bourbeau, Jean Bourbeau (390252), Francois Maltais (2342827), Paul Hernandez, Denis E O'Donnell, Shawn Aaron, J. Mark FitzGerald (115951), Don D Sin, Wan C. Tan (390251)   +24 more
core   +1 more source

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2020
Donald P Tashkin Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USACorrespondence: Donald P TashkinDavid Geffen School of Medicine at UCLA, 10388 Le Conte Avenue, Los Angeles, CA 90095, USATel +1 310 825 3163Fax +1 310 ...
Tashkin DP
doaj  

A study of correlation between body mass index and GOLD staging of chronic obstructive pulmonary disease patients

The Journal of Association of Chest Physicians, 2013
Background: The association between low body mass index (BMI) and poor prognosis of patients with chronic obstructive pulmonary disease (COPD) is a common clinical observation and it varies with different stages of COPD. Aims: To find out any correlation
Mrinmoy Mitra, Santanu Ghosh, Kaushik Saha, Arnab Saha, Prabodh Panchadhyayee, Anirban Biswas, Tarasankar Malik, Arnab Roy, Pratik Barma   +8 more
doaj   +1 more source

Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science

Clinical Pharmacology &Therapeutics, EarlyView.
New Approach Methodologies (NAMs) represent a paradigm shift in drug development and regulatory science, offering human‐relevant alternatives to traditional preclinical models. This mini‐review highlights recent advances in NAM development, validation, and regulatory application from FDA's Division of Applied Regulatory Science (DARS).
Ksenia Blinova, Kimberly Chiu, Anik Chaturbedi, Jahan Cooper, Tromondae K. Feaster, Paula L. Hyland, Lidiya Stavitskaya, Wendy W. Wu, Jeffry Florian, Rodney Rouse   +9 more
wiley   +1 more source

Evaluation of oral health of 6 to 10-year-old asthmatic children receiving bronchodilator through inhaler

Indian Journal of Dental Research, 2019
Aim: The aim of this study was to evaluate the oral health status in 6 to 10-year-old asthmatic children receiving bronchodilator (salbutamol, salmeterol, etc.) through inhaler and compare them with nonasthmatic healthy children. Settings and Design: The
Sudhir Kumar, Namita Kalra, Rishi Tyagi, M M A Faridi, Amit Khatri, V N V Satish   +5 more
doaj   +1 more source